Antithrombotic therapy in the elderly: The more we know, the more we can offer

Int J Cardiol. 2021 Sep 15:339:58-59. doi: 10.1016/j.ijcard.2021.06.054. Epub 2021 Jul 6.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Aged
  • Anticoagulants
  • Fibrinolytic Agents* / adverse effects
  • Humans
  • Warfarin*

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Warfarin